Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Vaccine Adjuvants
Saponin QS-21 Has Potential as Mucosal Adjuvant
March 31st, 2000
Saponin QS-21 may be useful as a mucosal vaccine adjuvant, reported researchers from the United States. "QS-21 is a purified triterpene glycoside adjuvant derived from the bark of the South American tree Quillaja saponaria Molina," explained Charlotte Read Kensil from Aquila Biopharmaceuticals, Inc., Massachusetts, USA. "It has received extensive preclinical evaluation as a parenteral adjuvant." Kensil presented data from her work at the 6th United Kingdom - Ireland Controlled Release Society Symposium: Novel Vaccine Formulations and Delivery Systems, held in Dublin, Ireland. The title of her presentation was "Potential of the saponin QS-21...
Source: Drug Week (2000-03-31)
|
